Founded in 1980, Celgene Corporation is a full-service, multinational biopharmaceutical company. It has been approved by the Food Drug and Administration to market the THALOMID brand products used in the treatment of erythema nodosum leprosum. The company offers products from the VIDAZA, REVLIMID and ALKERAN brands. Celgene Corporation provides placental and cord blood banking services through LifebankUSA. The company conducts investigation compound studies on patients with hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndrome, chronic lymphocyte leukemia and glioblastoma. It also offers research and development, patient support and medical services for individuals. Celgene Corporation has a staff of more than 1,500 employees.